FDA approves OneTouch VerioSync Blood Glucose monitoring system (LifeScan) for patients with Diabetes Types 1 & 2

The OneTouch VerioSync Blood Glucose Monitoring System from LifeScan, has received clearance from the FDA for use by patients with Diabetes Types 1 & 2. It is the first meter to automatically send blood glucose results wirelessly via Bluetooth technology to an iPhone, iPad or iPod touch using the OneTouch Reveal mobile app. Through the OneTouch Reveal mobile app, users will be able to view a variety of personalized information directly on their mobile device including a 14-day summary of blood sugar test results, simple visuals showing the percentage of test results within target range, and then share that information via email or text with their care providers, family or friends.